We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Nouveau Life Pharmaceuticals Inc (PK) | USOTC:NOUV | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.0002 | 0.0001 | 0.0002 | 0.00 | 12:22:05 |
DALLAS, TX -- December 17, 2018 -- Investorshub NewsWire -- Puration, Inc. (USOTC: PURA) (“PURA”) today announced that management anticipates 2018 sales may exceed the previously announced $1 million sales goal. The company has recently announced new EVERx CBD Sports Water sales in Georgia and Colorado. On Friday, PURA announced a 100 pallet Telluride Happy Water order is going to Austin, Texas to the same distributor that order twelve pallets last month. PURA expects to announce later this month one and maybe even two more new distributer orders opening new geographical regions. EVERx CBD Sports Water is also expected to go on sale online later this month on the new USMJ E-commerce site soon to be launched by North American Cannabis Holdings, (USOTC: USMJ). Management plans to release an online presentation this Thursday, December, 20th, 2018 to update shareholders on progress against the company’s business plan to include exciting updates on the planned dividend of Nouveau (USOTC: NOUV) stock to PURA shareholders in conjunction with the recent spinoff of PURA’s cannabis cultivation operation to NOUV.
Learn more at www.purationinc.com.
Disclaimer/Safe Harbor:
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800) 861-1350
1 Year Nouveau Life Pharmaceuti... (PK) Chart |
1 Month Nouveau Life Pharmaceuti... (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions